Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate Cancer
- 1 July 2014
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 192 (1) , 75-81
Abstract
We examined variation in active surveillance use in Medicare eligible men undergoing expectant treatment for early stage prostate cancer. Using SEER (Surveillance, Epidemiology and End Results) and Medicare data we identified 49,192 men diagnosed with localized prostate cancer from 2004 through 2007. Of 7,347 patients who did not receive treatment (ie expectant management) within 12 months of diagnosis we assessed the prevalence of active surveillance (ie repeat prostate biopsy and prostate specific antigen measurement) vs watchful waiting across health care markets. We fit multivariable logistic regression models to examine associations of active surveillance with patient demographics, cancer severity and health care market characteristics. During the study interval use of active surveillance vs watchful waiting increased significantly in patients treated expectantly from 9.7% in 2004 to 15.3% in 2007 (p <0.001). Active surveillance was less common in older patients, those with high risk tumors and those with more comorbidities (each p <0.001). Patients who were white and had higher socioeconomic status were more likely to receive active surveillance (each p <0.05). After adjusting for patient and tumor characteristics significant differences in the predicted probability of active surveillance persisted across health care markets (range 2.4% to 30.1%). No significant variation in active surveillance use was associated with specific health care market characteristics, including intensity of end of life care, Medicare reimbursement or provider density. Active surveillance has been relatively uncommon in Medicare beneficiaries with localized prostate cancer. Its use relative to watchful waiting varies based on patient demographics, tumor severity and geographic location.Keywords
This publication has 23 references indexed in Scilit:
- Active Surveillance for Prostate Cancer: Progress and PromiseJournal of Clinical Oncology, 2011
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2011
- Overdiagnosis in CancerJNCI: Journal of the National Cancer Institute, 2010
- Time Trends and Local Variation in Primary Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2010
- Outcomes of Localized Prostate Cancer Following Conservative ManagementJAMA, 2009
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007
- The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of CareAnnals of Internal Medicine, 2003
- Development of a comorbidity index using physician claims dataJournal of Clinical Epidemiology, 2000
- Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care researchJournal of Clinical Epidemiology, 1997
- Completeness of hospital cancer case reporting from the SEER program of the national cancer instituteCancer, 1995